L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells

Zhongqi Li1, Diana Oganesyan1, Rachael Mooney1

  • 1Department of Developmental and Stem Cell Biology, City of Hope National Medical Center and Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.

Stem Cell Reports
|August 23, 2016
PubMed

Insights

A new human neural stem cell (NSC) line, LM-NSC008, shows promise for treating central nervous system (CNS) damage. These cells are non-tumorigenic and migrate to injury sites, supporting their therapeutic potential in traumatic brain injury (TBI).

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Neural stem cells (NSCs) offer therapeutic potential for central nervous system (CNS) damage.
  • Limitations of patient-derived NSCs necessitate the development of immortalized cell lines.
  • Immortalized NSCs are crucial for advancing cell replacement and regenerative therapies.

Purpose of the Study:

  • To generate and characterize a novel immortalized human fetal neural stem cell line (LM-NSC008).
  • To evaluate the therapeutic potential of LM-NSC008 cells in preclinical models of CNS injury.

Main Methods:

  • Generation of immortalized human fetal neural stem cells (NSCs) via L-MYC transduction.
  • In vitro characterization of self-renewal and multipotent differentiation capabilities.
  • In vivo assessment of non-tumorigenicity, migration to glioma xenografts, and homing to traumatic brain injury (TBI) sites.

Main Results:

  • LM-NSC008 cells demonstrated robust self-renewal and differentiated into neurons, oligodendrocytes, and astrocytes in vitro.
  • These cells were non-tumorigenic in vivo and migrated effectively to orthotopic glioma xenografts.
  • Intranasal administration showed specific distribution of LM-NSC008 cells to traumatic brain injury (TBI) sites.

Conclusions:

  • The immortalized LM-NSC008 cell line possesses key characteristics for therapeutic applications in CNS disorders.
  • LM-NSC008 cells show promise for allogeneic transplantation in traumatic brain injury (TBI) and other neurological conditions.
  • This study supports the further development of LM-NSC008 for clinical use in regenerative medicine.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K